Boston Scientific Invests in MiRus to Enhance TAVR Offerings
May 18, 2026, 6:33 AM EDT4 sourcesAI-analyzed
Why it may matterVerify against the original reporting
This investment could enhance BSX's market position in TAVR, likely leading to increased investor confidence and stock demand.
AI summary
What happened, with direct paths to the underlying reporting
Boston Scientific has committed $1.5 billion for a 34% stake in MiRus LLC, gaining an exclusive option to acquire the revolutionary SIEGEL balloon-expandable TAVR system. This strategic move aims to enhance BSX's offerings in cardiovascular treatments, potentially positioning the company for growth in a rapidly evolving market.
BSX invests $1.5 billion for a 34% stake in MiRus LLC.
Agreement includes an exclusive option to acquire MiRus' TAVR system.
SIEGEL valve aims to improve TAVR treatments for aortic stenosis.
Investment expected to have immaterial impact on BSX's 2026 earnings.
Approval for SIEGEL TAVR valve is still pending regulatory review.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Boston Scientific disclosed a cybersecurity incident that disrupted its global operations, including order-processing and shipping systems. The lack of detail on the cause or reme…
Boston Scientific trimmed its annual profit forecast after signaling ongoing weakness in the Watchman left atrial appendage closure device business. The revision suggests the Watc…
Boston Scientific disclosed board approval of a company-wide restructuring to cut costs and strengthen growth prospects. The Monday regulatory filing offered few specifics on savi…
Boston Scientific shares dropped about 12% to a multi-year low after flagging declining usage of its heart-disease device. The comments suggest softer utilization in a core franch…
StockNews.AISignal intelligence